Page last updated: 2024-09-02

anecortave acetate and Diabetic Retinopathy

anecortave acetate has been researched along with Diabetic Retinopathy in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Joussen, AM; Kirchhof, B	1
Campochiaro, PA	1
Emerson, MV; Lauer, AK	1

Reviews

2 review(s) available for anecortave acetate and Diabetic Retinopathy

Article	Year
Ocular neovascularisation and excessive vascular permeability. Expert opinion on biological therapy, 2004, Volume: 4, Issue:9 Topics: Angiogenesis Inhibitors; Angiopoietins; Angiostatins; Capillary Permeability; Clinical Trials as Topic; Corneal Neovascularization; Diabetic Retinopathy; Drug Delivery Systems; Endostatins; Extracellular Matrix Proteins; Eye Proteins; Gene Transfer Techniques; Genetic Therapy; Humans; Macular Edema; Nerve Growth Factors; Neuropilins; Pregnadienediols; Receptor, TIE-2; Receptors, Vascular Endothelial Growth Factor; Serpins; Signal Transduction; Tissue Inhibitor of Metalloproteinase-3; Vascular Endothelial Growth Factor A	2004
Emerging therapies for the treatment of neovascular age-related macular degeneration and diabetic macular edema. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 2007, Volume: 21, Issue:4 Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Cholestanols; Choroidal Neovascularization; Diabetic Retinopathy; Drug Therapy, Combination; Humans; Indoles; Lactates; Laser Coagulation; Macular Degeneration; Macular Edema; Maleimides; Octreotide; Photochemotherapy; Photosensitizing Agents; Porphyrins; Pregnadienediols; Protein-Tyrosine Kinases; Vascular Endothelial Growth Factors; Verteporfin; Vitrectomy	2007

Article

Year

Ocular neovascularisation and excessive vascular permeability.

Expert opinion on biological therapy, 2004, Volume: 4, Issue:9

Topics: Angiogenesis Inhibitors; Angiopoietins; Angiostatins; Capillary Permeability; Clinical Trials as Topic; Corneal Neovascularization; Diabetic Retinopathy; Drug Delivery Systems; Endostatins; Extracellular Matrix Proteins; Eye Proteins; Gene Transfer Techniques; Genetic Therapy; Humans; Macular Edema; Nerve Growth Factors; Neuropilins; Pregnadienediols; Receptor, TIE-2; Receptors, Vascular Endothelial Growth Factor; Serpins; Signal Transduction; Tissue Inhibitor of Metalloproteinase-3; Vascular Endothelial Growth Factor A

2004

Emerging therapies for the treatment of neovascular age-related macular degeneration and diabetic macular edema.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 2007, Volume: 21, Issue:4

Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Cholestanols; Choroidal Neovascularization; Diabetic Retinopathy; Drug Therapy, Combination; Humans; Indoles; Lactates; Laser Coagulation; Macular Degeneration; Macular Edema; Maleimides; Octreotide; Photochemotherapy; Photosensitizing Agents; Porphyrins; Pregnadienediols; Protein-Tyrosine Kinases; Vascular Endothelial Growth Factors; Verteporfin; Vitrectomy

2007

Other Studies

1 other study(ies) available for anecortave acetate and Diabetic Retinopathy

Article	Year
[Angiogenesis in ophthalmology. A theme with a future]. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2003, Volume: 100, Issue:4 Topics: Adult; Angiogenesis Inhibitors; Antineoplastic Agents; Choroidal Neovascularization; Corneal Neovascularization; Diabetic Retinopathy; Endothelial Growth Factors; Eye Diseases; Humans; Infant, Newborn; Intercellular Signaling Peptides and Proteins; Lymphokines; Macular Degeneration; Metalloendopeptidases; Neovascularization, Pathologic; Organic Chemicals; Platelet-Derived Growth Factor; Pregnadienediols; Retinal Neovascularization; Retinopathy of Prematurity; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	2003

Article

Year

[Angiogenesis in ophthalmology. A theme with a future].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2003, Volume: 100, Issue:4

Topics: Adult; Angiogenesis Inhibitors; Antineoplastic Agents; Choroidal Neovascularization; Corneal Neovascularization; Diabetic Retinopathy; Endothelial Growth Factors; Eye Diseases; Humans; Infant, Newborn; Intercellular Signaling Peptides and Proteins; Lymphokines; Macular Degeneration; Metalloendopeptidases; Neovascularization, Pathologic; Organic Chemicals; Platelet-Derived Growth Factor; Pregnadienediols; Retinal Neovascularization; Retinopathy of Prematurity; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2003